Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrospective Review of Alternate PROCRIT Dosing
NCT00495378Phase 4Terminated
- Sponsor
- Ortho Biotech Inc.
- Start
- Nov 2002
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
Phase 4, open-label, single-arm trial of epoetin alfa in anemia, sponsored by Ortho Biotech Inc. Primary endpoints: Frequency and percentage of subjects in each dosing regimen, Hemoglobin response and maintenance of initial treatment phase Hb and 1 more. Started Nov 2002; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00495378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00495378.